ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.405,64
-1,10%
S&P 500
5.291,34
0,15%
Dow Jones
38.711,29
0,36%
Euro vs US Dollar
1,08855
0,04%
Bitcoin
70.866,17
0,43%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Vascular Biogenics Ltd (VBLT)

  7. Vascular Biogenics Ltd (VBLT) News

VBLT

Vascular Biogenics (VBLT)

Vascular Biogenics Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:VBLT
DatumZeitQuelleÜberschriftSymbolFirma
10/05/202423h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
10/05/202423h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
10/05/202423h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
10/05/202423h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
10/05/202423h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
10/05/202423h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
06/05/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
19/04/202422h56Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VBLTVascular Biogenics Ltd
12/04/202414h44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
11/04/202423h00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VBLTVascular Biogenics Ltd
09/04/202423h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
08/04/202418h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
01/04/202422h30Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:VBLTVascular Biogenics Ltd
25/03/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
22/02/202414h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
22/02/202414h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
16/02/202415h00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VBLTVascular Biogenics Ltd
05/02/202423h00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VBLTVascular Biogenics Ltd
02/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
26/01/202417h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
26/01/202417h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
26/01/202417h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
26/01/202417h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
26/01/202417h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
11/01/202423h22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
08/01/202422h21Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:VBLTVascular Biogenics Ltd
03/01/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
02/01/202423h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
28/12/202323h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
26/12/202323h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
 Showing the most relevant articles for your search:NASDAQ:VBLT

Kürzlich von Ihnen besucht

CCOM
US30
US 30
COIN
BTCUSD
Bitcoin
AMEX
XLE
Energy Select Sector SPDR
NYSE
JPM
JP Morgan Chase
FX
EURGBP
Euro vs Sterling
CCOM
SILVER
SILVER
NYSE
MRK
Merck
TG
DBK
Deutsche Bank
USOTC
RHHBY
Roche (QX)
NASDAQ
AAPL
Apple
TG
TUI1
Tui
PM
XAUUSD
Gold vs US Dollar
NASDAQ
GOOGL
Alphabet
AMEX
XLV
Health Care Select Sector
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten